PBH
NYSEPrestige Consumer Healthcare Inc.
Website
News25/Ratings11
News · 26 weeks18-100%
2025-10-262026-04-19
Mix1090d
- Insider3(30%)
- SEC Filings3(30%)
- Earnings2(20%)
- Other2(20%)
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G/A - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal StripsEntered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 millionBreathe Right is an iconic and category‑leading brand with strong margins and cash flow generationAcquisition reinforces Prestige's long-term organic growth algorithmTransaction expected to close in Prestige's first half fiscal 2027 TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the "Company" or "Prestige") (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated ta
- INSIDERSenior VP Operations Zerillo Jeffrey sold $65,930 worth of shares (1,000 units at $65.93), decreasing direct ownership by 2% to 41,048 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G/A - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECSEC Form 10-Q filed by Prestige Consumer Healthcare Inc.10-Q - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 ResultsRevenue of $283.4 million in Q3, ahead of outlookDiluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22Repurchased approximately 0.8 million shares opportunistically in Q3Successfully closed acquisition of eye care supplier Pillar5 Pharma, Inc. in December, as expectedNarrowing Outlook Range of Fiscal 2026 Revenue and Adjusted Diluted EPS TARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and nine months ended December 31, 2025. "We exceeded our third quarter revenue outlook and delivered solid profitability in the quarter, which
- INSIDEROfficer Rosado Jose Luis was granted 3,426 shares, increasing direct ownership by 34,260% to 3,436 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERNew insider Rosado Jose Luis claimed ownership of 10 shares (SEC Form 3)3 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- PRPrestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR ConferenceTARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the "Company" or "Prestige") (NYSE:PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recomme
- INSIDERSenior VP Operations Zerillo Jeffrey sold $60,000 worth of shares (1,000 units at $60.00), decreasing direct ownership by 2% to 42,048 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERDirector Byom John E sold $178,050 worth of shares (3,000 units at $59.35), decreasing direct ownership by 5% to 51,594 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- SECSEC Form 144 filed by Prestige Consumer Healthcare Inc.144 - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECSEC Form SCHEDULE 13G filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECSEC Form 10-Q filed by Prestige Consumer Healthcare Inc.10-Q - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 ResultsRevenue of $274.1 million in Q2, ahead of outlookDiluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09Repurchased approximately 1.1 million shares opportunistically in Q2Fiscal 2026 revenue outlook unchanged; Adjusted Diluted EPS outlook updated to $4.54 to $4.58, high end of previous range TARRYTOWN, N.Y., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first six months ended September 30, 2025. "Our second quarter results surpassed our sales and earnings expectations helped primarily by Clear Eyes® supply timing and the timing of certain retailer
- PRPrestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings ResultsTARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to joi
- ANALYSTPrestige Consumer upgraded by Sidoti with a new price targetSidoti upgraded Prestige Consumer from Neutral to Buy and set a new price target of $80.00
- NEWSSidoti Events, LLC's Virtual September Small-Cap ConferenceNEW YORK, NY / ACCESS Newswire / September 16, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day September Small-Cap Conference taking place Wednesday and Thursday, September 17-18, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links. Presentation Schedule*All Times EDTWednesday, September 17, 2025 (Day 1)8:30-9:00*****Columbus McKinnon Corp (NASDAQ:CMCO)Uxin Ltd (NASDAQ:UXIN)9:15-9:45M-tron Industries, Inc. (NYSE:MPTI)ParkOhio Holdings Corp (NASDAQ:PKOH)*****10:00-10:30Charles River Associates (NASDAQ:CRAI)High Tide, Inc. (NA
- PRPrestige Consumer Healthcare to Present at the Barclays Global Consumer Staples ConferenceTARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September 4, 2025 at 12:45 p.m. ET. All interested parties may access a live webcast of this event at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be available on the Company's website following the event. About Prestige Consumer Healthcare Inc. Prestige Consumer H
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G/A - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECSEC Form 10-Q filed by Prestige Consumer Healthcare Inc.10-Q - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)